Monique V Davies

This inventor holds 11 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Wyeth, Medimmune Limited, Acceleron Pharma Inc.. Active years: 2007-2017.

USPTO Granted Patents = 11

% Patents Active = 27.3

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 8.1

ph-index = 7

Forward Citations = 414(Granted Patents)

Location History:

Harpswell, MA (US) (2008 - 2016)
Harpswell, ME (US) (2007 - 2017)

Company Filing History:

Acceleron Pharma Inc.

patents

4. 1 out of 28

Cambridge Antibody Technology Limited

6. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2007-2017

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9624301 - Polynucleotides encoding an actriib antibody (2017-04-18),

2. 9505831 - Isolated cell comprising a nucleic acid encoding antibody inhibitors of gdf-8 and uses thereof (2016-11-29),

3. 8940874 - Neutralizing antibodies against GDF-8 and uses therefor (2015-01-27),

4. 8765385 - Method of detection of neutralizing anti-actriib antibodies (2014-07-01),

5. 8710202 - Isolated nucleic acid molecule encoding an antibody that reduces GDF-8 activity (2014-04-29),

6. 8420082 - Neutralizing antibodies against GDF-8 and uses therefor (2013-04-16),

7. 8092798 - Method of increasing trabecular bone density in a patient in need thereof by an antibody against GDF-8 (2012-01-10),

8. 7731961 - Methods of increasing muscle mass or muscle strength using antibody inhibitors of GDF-8 (2010-06-08),

9. 7655763 - Neutralizing antibodies against GDF-8 and uses therefor (2010-02-02),

10. 7320789 - Antibody inhibitors of GDF-8 and uses thereof (2008-01-22),

11. 7261893 - Neutralizing antibodies against GDF-8 and uses therefor (2007-08-28),

Title: Monique V Davies: Innovator in Antibody Research

Introduction

Monique V Davies is a prominent inventor based in Harpswell, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins involved in various biological processes. With a total of 11 patents to her name, her work has the potential to impact medical treatments and therapies.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Polynucleotides encoding an ActRIIB antibody." This patent discloses neutralizing antibodies and portions thereof that bind to ActRIIB, along with their various uses. Another notable patent is for "Isolated cell comprising a nucleic acid encoding antibody inhibitors of GDF-8 and uses thereof." This invention provides novel antibodies against growth and differentiation factor-8 (GDF-8), including antibody fragments that inhibit GDF-8 activity both in vitro and in vivo. The patent also outlines methods for diagnosing, preventing, or treating degenerative disorders related to muscle, bone, or insulin metabolism.

Career Highlights

Throughout her career, Monique has worked with esteemed companies such as Wyeth and MedImmune Limited. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in antibody research.

Collaborations

Monique has collaborated with notable professionals in her field, including Geertruida Machteld Veldman and Neil M Wolfman. These partnerships have further enriched her research and development efforts.

Conclusion

Monique V Davies stands out as an influential inventor in the realm of biotechnology, with her innovative patents paving the way for future advancements in medical science. Her work continues to inspire and drive progress in the field of antibody research.